{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:46:56Z","timestamp":1757540816550},"reference-count":21,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T00:00:00Z","timestamp":1318809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Congestive Heart Failure"],"published-print":{"date-parts":[[2012,11]]},"abstract":"<jats:p>\u00a92011 Wiley Periodicals Inc.<\/jats:p><jats:p>Extremely elevated serum brain natriuretic peptide (BNP) in cancer patients is a poorly understood phenomenon. The authors report three cases of patients with hematologic malignancies and serial N\u2010terminal pro\u2010BNP (NT\u2010proBNP) measurements with values in the range of tens to hundred thousands pg\/mL. Through matching NT\u2010proBNP results with clinical, laboratory, echocardiographic and radiologic data, the authors found that these patients demonstrated exaggerated responses to fluid overload. Patients with hematologic malignancies may have higher than expected values of NT\u2010proBNP in response to hypervolemic states. The authors hypothesize that this may be related to possible infiltration of the myocardium by substances produced in the setting of these diseases or due to proteins interfering with the assay.Congest Heart Fail.<\/jats:p>","DOI":"10.1111\/j.1751-7133.2011.00258.x","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T05:57:02Z","timestamp":1318831022000},"page":"333-336","source":"Crossref","is-referenced-by-count":11,"title":["Exaggerated NT\u2010proBNP Production in Patients With Hematologic Malignancies: A Case Series"],"prefix":"10.1111","volume":"18","author":[{"given":"Aileen","family":"Andreu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Guglin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,10,17]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2004.06.002"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2006.075713"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020233"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2008.40.3.121"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2004.038752"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2006.08.003"},{"key":"e_1_2_8_8_2","first-page":"S122","article-title":"Laboratory testing for B\u2010type natriuretic peptides (BNP and NT\u2010proBNP): clinical usefulness, utilization, and impact on hospital operations","volume":"124","author":"Melanson SE","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.coc.0000256101.04404.b0"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7133.2010.00178.x"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-5299.2007.06478.x"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.06.017"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.08.051"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.02.031"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2006.00963.x"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi631"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.1.288"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccn.2005.05.021"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000229144.97624.90"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0b013e31821d8f2d"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000261893.72811.0F"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0508782102"}],"container-title":["Congestive Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1751-7133.2011.00258.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1751-7133.2011.00258.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T12:51:39Z","timestamp":1698756699000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1751-7133.2011.00258.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,17]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.1111\/j.1751-7133.2011.00258.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1751-7133.2011.00258.x","archive":["Portico"],"relation":{},"ISSN":["1527-5299","1751-7133"],"issn-type":[{"value":"1527-5299","type":"print"},{"value":"1751-7133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,17]]}}}